M
etazoan cell membranes are supported by a two-dimensional protein network which lays closely apposed to the cytoplasmic surface face of the lipid bilayer. It is known as the ''membrane-associated cytoskeleton'' 1 and made up of three key components: spectrin, actin, and protein 4.1 (also called band 4.1 or simply 4.1). Protein 4.1 and a fourth cytoskeletal protein, called ankyrin, provide two links that function independently to tether the network to transmembrane proteins.
Vertebrates have four highly conserved genes encoding protein 4.1; their protein products are known as 4.1R (red cell type), 4.1N (neuron type), 4.1G (general type), and 4.1B (brain type). Protein 4.1R is the first member of protein 4.1 identified from red blood cells in 1979 2 , and is thus regarded as the prototypical member of protein 4.1 family. Protein 4.1R is predominantly expressed in red blood cells, although it is expressed in many other cell types. The other three proteins are essentially absent from red cells, but present widely in other cell types 3 . All four proteins have a common organization of domains (Fig. 1a) , such as the N-terminal domain FERM (four point one protein-ezrin-radixin-moesin), spectrin-actin-binding domain (SAB), and C-terminal domain (CTD). Adjacent to the FERM domain is a FERM-adjacent (FA) domain 4 . Both FERM and CTD domains can bind transmembrane proteins, and SAB domain provides the cytoskeletal linkage, except for that of protein 4.1N, which is so divergent that it does not bind spectrin and actin 5 . FA domain is the site of phosphorylation by a number of protein kinases, including protein kinase C. Interspersed between the common domains are nonconserved sequences that display far less identity between the individual proteins. They are called unique domains: U1 (also known as ''headpiece''), U2, and U3. Sequences of U1, U2, and U3 are distinct from each other and their functions remain poorly defined 6 . Accumulating data show that protein 4.1 emerged early in evolution; all known invertebrate genomes have a single copy of protein 4.1 genes 7 . For example, a protein 4.1 gene has been found in sea anemone Nematostella vectensis, although it lacks the SAB domain 4, 7 . Similarly, protein 4.1 homologue found in Drosophila does not have the SAB domain either 8 . Recently, we have isolated a cDNA in the basal chordate amphioxus (Branchiostoma japonicum) coding for protein 4.1, named BjP4.1, which possesses both the common domains FERM, CTD, and FA, and the unique domains U1, and U2/3, but not the SAB domain (Fig. 1b) . These data together indicate that the SAB domain is a late evolutionary development 9, 10 . The questions thus arise as to when the SAB domain of protein 4.1 emerged in evolution, and whether invertebrate protein 4.1 can bind spectrin and actin. To our best knowledge, no study has ever been conducted to examine the interaction of invertebrate protein 4.1 with spectrin and actin. Additionally, in contrast to the enormous progresses on vertebrate protein 4.1 structure-function study, little information as such is available for invertebrate protein 4.1. The aims of this study were therefore to explore whether amphioxus protein 4.1 can bind to spectrin and actin, and if so, which site would be essential for the binding to spectrin and actin.
Results
Sequence and phylogeny of BjP4.1. The cDNA of BjP4.1 obtained contained a longest open reading frame which codes for a protein of 529 amino acids with a predicted molecular mass of approximately 59.9 kDa. Sequence comparison revealed that the predicted protein BjP4.1 was 47.0% to 60.8% identical to the orthologs in fruit fly and vertebrates (Supplementary Figure S1 and Supplementary Table 1) . BLASTp searching at NCBI showed that BjP4.1 has an intact FERM domain at residues 42 to 315, a FA domain at residues 325 to 370 and a CTD domain at residues 439 to 526, but it lacks a recognizable SAB domain (Fig. 1b) . Therefore, BjP4.1 has a canonical domain combination, U1-FERM-FA-U2/3-CTD, characteristic of known invertebrate protein 4.1 members.
To investigate the relationship between BjP4.1 and other 4.1 proteins, a phylogenetic tree was constructed using the amino acid sequences of BjP4.1 and other representative 4.1 proteins (Supplementary Table 1 ) by neighbor joining method (Fig. 2a) (Fig. 2b) . The introns all begin with GT and end with an AG dinucleotide, sequences thought necessary for correct RNA splicing of various eukaryotic genes 11 . It was notable that human 4.1R, 4.1N, 4.1G, and 4.1B genes contained 21 exons, 22 exons, 20 exons and 23 exons, respectively. For human 4.1 proteins and BjP4.1, their FERM domains were both encoded by 8 exons, FA domains by 1 exon, and CTD domains by 4 exons. In addition, the exon-intron splice sites of both human 4.1 proteins and BjP4.1, including FERM, FA and CTD domains, are conserved (Fig. 2b) , i.e. they all have the same phase introns 12 . These indicate that the primary composition of human 4.1 proteins and amphioxus protein 4.1 is highly conserved across humans and basal chordate, although amphioxus protein 4.1 lacks the SAB domain.
Tissue-specific expression. qRT-PCR assay was used to examine the expression pattern of Bjp4.1 in the different tissues of amphioxus, including the hepatic caecum, hind-gut, gill, muscle, notochord, testis and ovary. The dissociation curve of amplification product showed only a single peak, indicating that the amplification was specific (data not shown). As shown in Fig. 3 , Bjp4.1 mRNA was predominantly detected in the hind-gut, gill, notochord, testis and ovary, and at a lower level it was present in the hepatic caecum. Little expression of Bjp4.1 was measured in the muscle. These show that Bjp4.1 is expressed in a tissue-specific fashion in B. japonicum.
Binding of rBjP4.1 to spectrin and actin. An expression vector, including the cDNA encoding BjP4.1 and a 59 additional His 6 tag, was constructed and transformed into Escherichia coli cells. The recombinant protein rBjP4.1 was induced by isopropyl b-Dthiogalactoside and was purified by affinity chromatography on a nickel-nitrilotriacetic acid resin column. SDS-PAGE followed by staining with Coomassie Brilliant Blue R-250 demonstrated the presence of a single band of approximately 66 kDa (Fig. 4a) , corresponding to the expected size. Additionally, Western blotting showed that the purified protein reacted with human EPB41 protein polyclonal antibody (Inc:sc-25967; Santa Cruz Biotechnology, California, USA), indicating that Bjp4.1 was correctly expressed (Fig. 4b) .
To test if rBjP4.1 can bind to spectrin and actin, an ELISA was carried out first. It was found that rBjP4.1 was capable of binding to both spectrin and F-actin in a dose-dependent manner (Fig. 4c) , while BSA was not, indicating that the interaction of rBjP4.1 with spectrin and actin was specific. To characterize the affinities of rBjP4.1 to spectin and actin, the Scatchard analysis was performed. It was shown that the Bmax (ng/pmol protein) and Kd values (mg/ml) of the affinities of rBjP4.1 to spectrin and F-actin were about 9.832 and 2.308, and 9.839 and 2.277 ( Fig. 4d and e), respectively. It was clear that the binding of rBjP4.1 to spectrin and F-actin was specific and saturable. Notably, the Bmax and Kd values of the affinities of recombinant human 4.1R to spectrin and F-actin were about 9.915 and 2.291, and 9.885 and 2.155 ( Fig. 4f and g ), individually. In comparison, the Bmax and Kd values of the affinities of rBjP4.1 to spectrin and F-actin were closely comparable to those of recombinant human 4.1R. Consistent with the ELISA results, no specific binding of BSA to spectrin and F-actin was detected by Scatchard analysis. These data denote that like human 4.1R, rBjP4.1 is able to specifically bind to spectrin and actin.
Affinity of truncated BjP4.1 peptides to spectrin and actin. To determine the structure-activity relationship, various truncated BjP4.1 peptides (FUC, UC, FU, FA, U2/3 and U 17/68 ), with the specific domains deleted (Fig. 5a ), were expressed in E. coli, purified (Supplementary Figure S2 ) and subjected to binding analysis. As shown in Fig. 5 , the truncated peptide FUC had an affinity to spectrin and actin, which is comparable to full rBjP4.1. Similarly, the truncated peptides UC, FU, U2/3, and U 17/68 retained strong affinities to spectrin and actin, although their binding activities were conspicuously reduced by the deletion of U1-FERM-FA, U1-FERM plus CTD, U1-FERM-FA plus CTD, and the N-terminal 16 residues of U2/3 (Fig. 5) . By contrast, the truncated peptide FA had no affinity to spectrin and actin (data not shown). Specifically, the Bmax and Kd values of the affinities of FUC, UC, FU, U2/3 and U 17/68 to spectrin and actin were ,8.122 and ,3.207, and ,7.857 and ,3.385 ( Fig. 5b and c) , ,4.519 and ,5.251, and ,4.397 and ,4.089 ( Fig. 5d and e) , ,4.66 and ,4.422, and ,4.543 and ,3.908 ( Fig. 5f and g) , and ,4.497 and ,5.393, and ,4.361 and ,4.198 ( Fig. 5h and i) as well as ,4.550 and ,4.597, and ,4.35 and ,3.675 ( Fig. 5j and k) , respectively.
Coimmunoprecipitation assay was also used to examine the interactions of rBjP4.1 and its truncated BjP4.1 peptides with spectrin and actin. An anti-His-tag antibody was utilized to immunoprecipitate rBjP4.1 and its recombinant truncated peptides, and the amount of cosedimenting spectrin or actin was quantified to estimate the binding capacity. Consistent with the Scatchard analysis results above, rBjP4.1 displayed a strong affinity to spectrin and actin, and the truncated peptides FUC, UC, FU, U2/3 and U 17/68 also retained considerable affinities to spectrin and actin ( Fig. 6a and b ). In contrast, the FA peptide did not bind spectrin and actin ( Fig. 6a and b) . These data together indicated that (1) the affinities of BjP4.1 to spectrin and actin were only slightly reduced by the deletion of U1-FERM domains; (2) the affinities of FUC to spectrin and actin were further reduced by the deletion of FA although it itself did not bind to spectrin and actin; (3) the affinities of U2/3 to spectrin and actin were very similar to those of FU and UC, i.e. the deletion of FA and CTD had little influence on the affinities of U2/3 to spectrin and actin; and (4) the affinities of U2/3 to spectrin and actin was not affected by the deletion of its N-terminal 16 residues. It is clear that although the presence of U1-FERM-FA contributes to the affinities of BjP4.1 to www.nature.com/scientificreports spectrin and actin, the U2/3 domain of BjP4.1 is the primary structure capable of interacting with spectrin and actin, and the deletion of its N-terminal 16 residues has little effect on the interaction of U2/3 with spectrin and actin.
U2/3 is a competitive inhibitor of spectrin-and actin-4.1R interaction. To further confirm the specific binding of U2/3 to spectrin and actin, we performed an ELISA to check if U2/3 can competitively inhibit the binding of spectrin and actin to human 4.1R. Spectrin and actin were both pre-incubated with increasing concentrations of U2/ 3 and then probed over immobilized human 4.1R. It was found that ,50% inhibition of the binding of spectrin and actin to immobilized human 4.1R was achieved at 12.5 and 3.13 mg/ml of U2/3, respectively (Fig. 7) . Similarly, the full length rBjP4.1 caused ,50% inhibition of the binding of spectrin and actin to immobilized human 4.1R at 6.25 and 3.13 mg/ml, and almost complete inhibition of the binding of spectrin and actin to human 4.1R at 50 mg/ml. By contrast, FA did not inhibit the binding at all even at a concentration of markers; Lane 1, total cellular extracts from E. coli BL21 containing pET28a/Bjp4.1 before induction; Lane 2, total cellular extracts from IPTG -induced E. coli BL21 containing pET28a/Bjp4.1; Lane 3, rBjP4.1 purified on Ni-NTA resin column. c, Binding of rBjP4.1 to spectrin and actin measured by ELISA. Spectrin and actin were applied to the wells of a 96-well microplate, air-dried overnight at room temperature, and followed by ELISA. BSA instead of spectrin or actin was used as control. d-g, Saturation curves of the binding of rBjP4.1 and recombinant human 4.1R to spectrin and actin. rBjP4.1 and human 4.1R dissolved in re-distilled water was applied to the wells of a 96-well microplate, air-dried overnight at room temperature, and followed by Scatchard analysis. BSA instead of rBjP4 or recombinant human 4.1R was used as control. 100 mg/ml. Furthermore, human 4.1R could also significantly inhibit the binding of spectrin and actin to immobilized U2/3 (Fig. 7d) , with ,50% inhibition of the binding of spectrin and actin to U2/3 achieved at 0.1 and 0.3 mg/ml of human 4.1R, respectively. Taken together, these results suggest that U2/3 is able to compete with human 4.1R for binding to spectrin and actin and vice versa, and the U2/3 domain of BjP4.1 is indeed the primary structure capable of interacting with spectrin and actin.
Affinity of U2/3-derived peptides to spectrin and F-actin. To pinpoint the key region of U2/3 (which consists of 68 residues) involved in binding to spectrin and actin, the different peptides, including U 1/16 , U 17/33 , U 34/50 and U 51/68 , were synthesized and subjected to the ELISA. It was found that the peptides U 1/16 , U 17/33 and U 34/50 had little affinities to spectrin and actin (Supplementary Figure S3) . By contrast, U 51/68 retained some affinities to spectrin and actin. As shown in Fig. 8 , the Bmax and Kd values of the affinities of U 51/68 to spectrin and actin were ,2.251 and ,5.737, as well as ,2.216 and ,5.351, that were about half of those of U2/3. These show that the C-terminal region of U2/3 consisting of 17 residues of U2/3 is the minimum structure which is still capable of binding to spectrin and actin. SAB domain functions to link transmembrane proteins with the underlying spectrin/actin cytoskeleton. It has been proposed that protein 4.1-spectrin-actin interactions arose with the vertebrates 9 . This seems to be supported by the reports that all the protein 4.1 members identified in invertebrates including sea anemone, fruit fly and ascidian lack a recognizable SAB domain 4, 7 . Surprisingly, we demonstrate here that amphioxus protein 4.1, BjP4.1, though lacking a recognizable SAB domain, is capable of binding to both spectrin and actin, with a binding capacity comparable to that of human protein 4.1. This reveals the presence of a ''cryptic'' spectrin-actin-binding activity in amphioxus protein 4.1, i.e. the capacity to bind spectrin and actin acquired with the advent of basal chordate. This suggests that the vertebrate-like membrane-associated cytoskeleton already evolved in the invertebrate species such as amphioxus. Whether the similar structure with spectrin-actinbinding activity is present in other invertebrate protein 4.1 remains to be determined.
Discussion
We then underwent to map the structure for the spectrin-actinbinding activity in BjP4.1. It is found that the truncated peptide FUC with U1-FERM depleted retains the spectrin-actin-binding capacity comparable to that of full BjP4.1, suggesting the existence of the spectrin-actin-binding activity in FA-U2/3-CTD domains. It is further shown that the peptide FA has no affinity to spectrin and actin, while U2/3 (U1-FERM-FA plus CTD deleted) retains a considerable spectrin-actin-binding activity, which is similar to that of the peptide UC (U1-FERM-FA deleted) . These suggest that the U2/3 domain is the primary structure for interaction of BjP4.1 with spectrin and actin, i.e. the U2/3 is a newly identified domain analogous to the SAB in vertebrate 4.1 proteins. The biochemical characterization of a SAB-like domain in amphioxus protein 4.1 will make it possible to identify additional interacting proteins.
To pinpoint the key region of U2/3 (which consists of 68 residues) involved in binding to spectrin and actin, the different peptides, including U 1/16 , U 17/33 , U 34/50 and U 51/68 , are synthesized and subjected to the binding assay. It is demonstrated that neither U 1/16 nor U 17/33 nor U 34/50 have the ability to bind spectrin and actin, but U 51/68 still retains some affinity to spectrin and actin. It is clear that the C-terminal 17 amino acids (PPTVEVKTETVKYVASDE) in U2/ 3 are the minimum sequence which retains the capacity to interact with spectrin and actin.
In summary, this study highlights the presence of an novel SABlike domain in amphioxus 4.1 protein, via showing that amphioxus 4.1 protein binds both spectrin and actin, and that the U2/3 is the primary region capable of interacting with spectrin and actin. It also suggests that amphioxus 4.1 protein gene represents the common ancestor of vertebrate 4.1 protein genes, from which vertebrate 4.1 protein genes originated. Taken together, these imply that the SAB domain probably evolved with the advent of chordates.
Methods
Cloning and sequencing of cDNA. Total RNAs were extracted with Trizol (TAKARA) from the amphioxus B. japonicum and polyA 1 RNA was purified using polyA tract mRNA isolation system II (Promega) according to the manufacturer's instructions. The first-strand cDNA was synthesized with reverse transcription system (Promega) using oligo d(T) primer. The specific primers (upstream primer 59-ATGCCGTCGGAGGAGGGTGTTA-39, and downstream primer 59-GCTGTCTTCATGCTGACTCTCTAC-39) were designed based on the putative protein 4.1 found in the Florida amphioxus B. floridae genome database (http://genome.jgipsf.org//Brafl1/Brafl1.home.html) 13 . To obtain the full sequence of B. japonicum protein 4.1 gene (Bjp4.1), PCR was performed using the first-strand cDNA as template.
The cDNA sequence obtained was analyzed for coding probability with the DNATools program. Comparison against the GenBank protein database was performed using the BLAST network server at NCBI 14 . Molecular mass (MW) and isoelectric point (pI) were determined using ProtParam (http://www.expasy.ch/tools/ protparam.html). Nuclear localization signal was predicted by the PSORT II (http:// psort.hgc.jp/form2.html). Protein domains were analyzed using the SMART program (http://smart.embl-heidelberg.de/). Multiple protein sequences were aligned using the MegAlign program by the CLUSTAL method in DNASTAR software package 15 . Phylogenetic tree was constructed by the neighbor-joining method 16 within the package MEGA 5.0 software package using 1000 bootstrap replicates 17 . The exonintron organization of amphioxus protein 4.1 gene was derived from NCBI database (http://www.ncbi.nlm.nih.gov/) and Ensembl database (http://www.ensembl.org). Quantitative real-time PCR (qRT-PCR). qRT-PCR was used to examine the expression profile of Bjp4.1 in the different tissues of B. japonicum. Total RNAs were prepared with Trizol (Invitrogen) from the whole animals and the different tissues including the hepatic caecum, hind-gut, gill, muscle, notochord, testis, and ovary. After digestion with RQ1 RNase-free DNase (Progema) to eliminate the genomic contamination, the RNAs were used to synthesized cDNAs with reverse transcription system using oligo d(T) primer, and the cDNAs were used as template. The PCR primer sets specific for Bjp4.1 (upstream primer 59-GGTCAAATATGTGGC CTCCGATG-39, and downstream primer 59-TGTGTGGTGGTTGTCGTGGA GATAG-39) and b-actin (upstream primer 59-TTCCAGCCTTCATTCCTCG-39, and downstream primer 59-CGGTGTTGGCGTACAGGTC-39) were designed using primer 5.0 program. After qualification of the cDNA template, qRT-PCR was performed on ABI 7500 real-time PCR system (Applied Biosystems, USA) as described by Wang et al 18, 19 . The b-actin gene was chosen as the reference for internal standardization.
Expression and purification of recombinant BjP4.1. The complete coding region of Bjp4.1 was amplified by PCR with the upstream primer 59-GCGAATTCATGCCGTCGGAGGAGGGTG-39 (EcoRI site is underlined), and the downstream primer 59-GGAAGCTTGCTGTTGGGTGTCGTCAGTCGTC-39 (HindIII site is underlined). The PCR product was digested with EcoRI and HindIII, respectively, and sub-cloned into the plasmid expression vector pET28a (Novagen) previously cut with the same restriction enzymes. The identity of the insert was verified by sequencing and the plasmid was designated pET28a/Bjp4.1.
The cells of Escherichia coli BL21 were transformed with the plasmid pET28a/ Bjp4.1. A single positive colony screened was cultured overnight in LB (LuriaBertani) broth containing kanamycin (50 mg/ml). The culture was diluted 15100 in LB broth and subjected to further incubation at 37uC for 5 h. Isopropyl-b-D-thiogalactoside (IPTG)-induced expression and purification of the recombinant protein were performed as described by Fan et al 20 . The eluted samples were analyzed by SDS/ PAGE (12% gel), followed by staining with Coomassie Brilliant Blue R-250. Protein concentrations were determined by the method of Bradford using bovine serum albumin as a standard.
Western blotting. The lysates of IPTG-induced E. coli BL21 cells with pET28a/Bjp4.1 and the recombinant BjP4.1 (rBjP4.1) purified were resolved by SDS/PAGE (12% gel with a 5% spacer gel). The lysates of non-induced E. coli BL21 cells with pET28a/ Bjp4.1 were also analysed as a negative control. The blots were performed and analyzed as described by Liu and Zhang 21 . The reaction was quenched with distilled water after the bands became visible.
